Literature DB >> 20872241

A combined analysis of genome-wide association studies in breast cancer.

Jingmei Li1, Keith Humphreys, Tuomas Heikkinen, Kristiina Aittomäki, Carl Blomqvist, Paul D P Pharoah, Alison M Dunning, Shahana Ahmed, Maartje J Hooning, John W M Martens, Ans M W van den Ouweland, Lars Alfredsson, Aarno Palotie, Leena Peltonen-Palotie, Astrid Irwanto, Hui Qi Low, Garrett H K Teoh, Anbupalam Thalamuthu, Douglas F Easton, Heli Nevanlinna, Jianjun Liu, Kamila Czene, Per Hall.   

Abstract

In an attempt to identify common disease susceptibility alleles for breast cancer, we performed a combined analysis of three genome-wide association studies (GWAS), involving 2,702 women of European ancestry with invasive breast cancer and 5,726 controls. Tests for association were performed for 285,984 SNPs. Evidence for association with SNPs in genes in specific pathways was assessed using a permutation-based approach. We confirmed associations with loci reported by previous GWAS on 1p11.2, 2q35, 3p, 5p12, 8q24, 10q23.13, 14q24.1 and 16q. Six SNPs with the strongest signals of association with breast cancer, and which have not been reported previously, were typed in two further studies; however, none of the associations could be confirmed. Suggestive evidence for an excess of associations was found for genes involved in the regulation of actin cytoskeleton, glycan degradation, alpha-linolenic acid metabolism, circadian rhythm, hematopoietic cell lineage and drug metabolism. Androgen and oestrogen metabolism, a pathway previously found to be associated with the development of postmenopausal breast cancer, was marginally significant (P = 0.051 [unadjusted]). These results suggest that further analysis of SNPs in these pathways may identify associations that would be difficult to detect through agnostic single SNP analyses. More effort focused in these aspects of oncology can potentially open up promising avenues for the understanding of breast cancer and its prevention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20872241     DOI: 10.1007/s10549-010-1172-9

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  59 in total

1.  Genetic variants at 14q24.1 and breast cancer susceptibility: a fine-mapping study in Chinese women.

Authors:  Hongxia Ma; Huizhang Li; Guangfu Jin; Juncheng Dai; Jing Dong; Zhenzhen Qin; Jiaping Chen; Shui Wang; Xinru Wang; Zhibin Hu; Hongbing Shen
Journal:  DNA Cell Biol       Date:  2012-02-07       Impact factor: 3.311

2.  Insights from Global Analyses of Long Noncoding RNAs in Breast Cancer.

Authors:  Andrew J Warburton; David N Boone
Journal:  Curr Pathobiol Rep       Date:  2017-01-23

3.  Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers.

Authors:  Yonglan Zheng; Temidayo O Ogundiran; Adeyinka G Falusi; Katherine L Nathanson; Esther M John; Anselm J M Hennis; Stefan Ambs; Susan M Domchek; Timothy R Rebbeck; Michael S Simon; Barbara Nemesure; Suh-Yuh Wu; Maria Cristina Leske; Abayomi Odetunde; Qun Niu; Jing Zhang; Chibuzor Afolabi; Eric R Gamazon; Nancy J Cox; Christopher O Olopade; Olufunmilayo I Olopade; Dezheng Huo
Journal:  Carcinogenesis       Date:  2013-03-08       Impact factor: 4.944

4.  Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions.

Authors:  David C Qian; Jinyoung Byun; Younghun Han; Casey S Greene; John K Field; Rayjean J Hung; Yonathan Brhane; John R Mclaughlin; Gordon Fehringer; Maria Teresa Landi; Albert Rosenberger; Heike Bickeböller; Jyoti Malhotra; Angela Risch; Joachim Heinrich; David J Hunter; Brian E Henderson; Christopher A Haiman; Fredrick R Schumacher; Rosalind A Eeles; Douglas F Easton; Daniela Seminara; Christopher I Amos
Journal:  Hum Mol Genet       Date:  2015-10-19       Impact factor: 6.150

Review 5.  Gene set analysis of genome-wide association studies: methodological issues and perspectives.

Authors:  Lily Wang; Peilin Jia; Russell D Wolfinger; Xi Chen; Zhongming Zhao
Journal:  Genomics       Date:  2011-04-30       Impact factor: 5.736

6.  Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome.

Authors:  Maral Jamshidi; Marjanka K Schmidt; Thilo Dörk; Montserrat Garcia-Closas; Tuomas Heikkinen; Sten Cornelissen; Alexandra J van den Broek; Peter Schürmann; Andreas Meyer; Tjoung-Won Park-Simon; Jonine Figueroa; Mark Sherman; Jolanta Lissowska; Garrett Teoh Hor Keong; Astrid Irwanto; Marko Laakso; Sampsa Hautaniemi; Kristiina Aittomäki; Carl Blomqvist; Jianjun Liu; Heli Nevanlinna
Journal:  Int J Cancer       Date:  2012-10-25       Impact factor: 7.396

7.  Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach.

Authors:  Katie M O'Brien; Stephen R Cole; Charles Poole; Jeannette T Bensen; Amy H Herring; Lawrence S Engel; Robert C Millikan
Journal:  Am J Epidemiol       Date:  2013-11-10       Impact factor: 4.897

8.  Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes.

Authors:  Jie Shen; Li Yan; Song Liu; Christine B Ambrosone; Hua Zhao
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

9.  Identification of novel susceptibility markers for the risk of overall breast cancer as well as subtypes defined by hormone receptor status in the Chinese population.

Authors:  Zhiping Deng; Hua Yang; Qiufang Liu; Zhouquan Wang; Tian Feng; Yongri Ouyang; Tianbo Jin; Hong Ren
Journal:  J Hum Genet       Date:  2016-09-08       Impact factor: 3.172

10.  Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.

Authors:  Erica S Rinella; Yongzhao Shao; Lauren Yackowski; Sreemanta Pramanik; Ruth Oratz; Freya Schnabel; Saurav Guha; Charles LeDuc; Christopher L Campbell; Susan D Klugman; Mary Beth Terry; Ruby T Senie; Irene L Andrulis; Mary Daly; Esther M John; Daniel Roses; Wendy K Chung; Harry Ostrer
Journal:  Hum Genet       Date:  2013-01-25       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.